DWA
MRNA icon

Delos Wealth Advisors’s Moderna MRNA Stock Holding History

Delos Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9
Closed -$1.07K – 301
2024
Q2 		$1.07K Hold
9
– – ﹤0.01% 249
2024
Q1 		$960 Buy
9
+8
+800% +$806 ﹤0.01% 260
2023
Q4 		$100 Hold
1
– – ﹤0.01% 328
2023
Q3 		$114 Hold
1
– – ﹤0.01% 363
2023
Q2 		$122 Hold
1
– – ﹤0.01% 364
2023
Q1 		$154 Hold
1
– – ﹤0.01% 372
2022
Q4 		$180 Hold
1
– – ﹤0.01% 373
2022
Q3 		$0 Buy
+1
New +$152 ﹤0.01% 337

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Delos Wealth Advisors's MRNA Position: Q3 2024 in Review

Delos Wealth Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 9 shares — an estimated $1.07K sold.

Delos Wealth Advisors first reported a position in MRNA in Q3 2022 and held it in 8 quarters. The position peaked at $1.07K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Delos Wealth Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Delos Wealth Advisors sold 9 Moderna shares in Q3 2024, an estimated $1.07K.
  • Delos Wealth Advisors first reported a position in Moderna in Q3 2022 and held it in 8 quarters.
  • Delos Wealth Advisors's Moderna position peaked at $1.07K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Delos Wealth Advisors's 13F filing for Q3 2024, filed 15 Nov 2024.